| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 376.03 | 407 | 365 | 401 |
| Cost of Material Consumed | 214.91 | 256 | 220 | 268 |
| Change in Inventory | -10 | -3 | -2 | -16 |
| Gross Margins | 45.51 | 37.84 | 40.27 | 37.16 |
| Employee Benefit Expenses | 35.29 | 49 | 56 | 63 |
| Other Expenses | 69.89 | 73 | 74 | 83 |
| EBITDA | 65.94 | 32 | 17 | 30 |
| OPM | 17.54 | 7.86 | 4.66 | 0.75 |
| Other Income | 1.95 | 3 | 6 | 26 |
| Finance Cost | 19.25 | 32 | 37 | 39 |
| D&A | 40.82 | 42 | 35 | 29 |
| EBIT | 25.12 | -10 | -18 | -26 |
| EBIT Margins | 6.68 | -2.46 | -4.93 | -6.48 |
| PBT | 7.8 | -39 | -50 | -19 |
| PBT Margins | 2.07 | -9.58 | -13.7 | -4.74 |
| Tax | 4.79 | -4 | -7 | 10 |
| PAT | 3.01 | -35 | -43 | -29 |
| NPM | 0.8 | -8.6 | -11.78 | -7.23 |
| EPS | 7.64 | -87.72 | -74.01 | -49.91 |
| Financial Ratios | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 17.54 | 7.86 | 4.66 | 0.75 |
| Net Profit Margin | 0.8 | -8.6 | -11.78 | -7.23 |
| Earning Per Share (Diluted) | 7.64 | -87.72 | -74.01 | -49.91 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 221.42 | 297 | 278 | 252 |
| CWIP | 24.97 | 9 | 2.3 | 0.5 |
| Investments | 182.64 | 188 | 199 | 179 |
| Trade Receivables | 58.39 | 38 | 46 | 86 |
| Inventory | 96.45 | 130 | 116 | 132 |
| Other Assets | 59.65 | 65 | 111.7 | 75.5 |
| Total Assets | 643.52 | 727 | 753 | 725 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 3.94 | 3.99 | 5.81 | 5.81 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | 275.71 | 264 | 260 | 230 |
| Borrowings | 307.74 | 423 | 450 | 434 |
| Trade Payables | 13.12 | 15 | 13 | 32 |
| Other Liabilities | 43.01 | 21.01 | 24.19 | 23.19 |
| Total Liabilities | 643.52 | 727 | 753 | 725 |
| Cash-Flow Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PBT | 7.8 | -39 | -50 | -60 |
| OPBWC | 71.24 | 32.7 | 20 | 5 |
| Change in Receivables | 17.42 | -0.9 | -8 | -40 |
| Change in Inventories | -41.34 | -26.4 | 14 | -16 |
| Change in Payables | 8.87 | -12.5 | 0 | 19 |
| Other Changes | -15.21 | 2.26 | 0 | 3 |
| Working Capital Change | -30.26 | -37.54 | 6 | -34 |
| Cash Generated From Operations | 40.98 | -4.84 | 26 | -29 |
| Tax | -2.23 | -0.6 | 1 | 0 |
| Cash Flow From Operations | 38.75 | -5.44 | 27 | -29 |
| Purchase of PPE | -49.8 | -68 | -17 | -1.5 |
| Sale of PPE | 3.67 | 2 | 5 | 4 |
| Cash Flow From Investment | -48.13 | -67 | -14 | 45 |
| Borrowing | 43.8 | 97 | 28 | -25 |
| Dividend | -0.19 | -0.4 | -0.19 | 0 |
| Equity | 0 | 0 | 36.5 | 0 |
| Others From Financing | -28.74 | -30.6 | -39.31 | -31 |
| Cash Flow from Financing | 14.87 | 66 | 25 | -56 |
| Net Cash Generated | 5.49 | -6.44 | 38 | -40 |
| Cash at the Start | 3.91 | 9.5 | 3 | 41 |
| Cash at the End | 9.4 | 3.06 | 41 | 1 |
Ramaraju Surgical Cotton Mills Limited is a well-established Indian textile and healthcare-materials manufacturer known for producing high-quality surgical cotton, absorbent products, and medical-grade textiles. Founded as part of the well-known Ramco Group, the company has built a strong reputation for reliability, hygiene standards, and consistent manufacturing processes. With decades of experience in the healthcare textile industry, the company serves hospitals, medical institutions, pharmaceutical companies, and export markets. Its commitment to quality control, innovation in product development, and adherence to global safety standards have helped it maintain a solid market presence in the medical consumables sector.
The company’s operations span the manufacture of absorbent cotton wool, bandages, gauze, and other medical-grade textile products essential for clinical and surgical applications. Ramaraju Surgical Cotton Mills benefits from backward integration, strong supply chain management, and access to the Ramco Group’s infrastructure and expertise. Its stable customer base and consistent demand for essential healthcare consumables help the company maintain steady revenue streams, even during market fluctuations. The company also focuses on cost-efficient production, advanced machinery, and sustainable material handling, giving it a competitive advantage in both domestic and international markets. With the healthcare sector in India expanding, demand for high-quality surgical cotton continues to rise, further strengthening the company’s long-term business outlook.
Ramaraju Surgical Cotton Mills Limited’s unlisted shares may appeal to investors seeking exposure to the healthcare consumables segment, which is known for its stable demand and lower cyclicality compared to other manufacturing sectors. The company’s strong lineage within the Ramco Group enhances investor confidence, while its consistent operational performance provides reassurance regarding long-term value creation. As India’s healthcare infrastructure grows and medical consumption increases across public and private sectors, the company stands to benefit from rising production volumes and expanding markets. However, investors should also consider factors such as liquidity risks associated with unlisted shares, limited publicly available financial disclosures, and market competition. Overall, the company offers a balanced investment prospect for long-term, fundamentals-focused investors.
Q:1 How can I confirm the booking of Ramaraju Surgical Cotton Mills Limited Unlisted Shares?Answer: You can confirm the booking by contacting us and agreeing on a trading price for the shares.
Q:2 What documents do I need to provide to buy Ramaraju Surgical Cotton Mills Limited Unlisted Shares?Answer: You need to provide your client master report (CMR), PAN Card, and a Cancelled Cheque if you are not transferring funds from the bank account mentioned in the CMR.
Q:3 Why are KYC documents required when purchasing unlisted shares?Answer: KYC (Know Your Customer) documents are required as per SEBI regulations to ensure transparency and compliance in financial transactions.
Q:4 How do I make the payment for the shares?Answer: You need to transfer funds to the bank account we provide, using RTGS, NEFT, IMPS, or cheque transfer.Please note that cash deposits are not allowed.
Q:5 Can I pay for the shares using a different bank account than the one mentioned in the CMR?Answer: No, payment must be made from the same bank account in which the shares will be credited.
Q:6 What is the payment method accepted for purchasing shares?
Answer: Payments can be made via RTGS, NEFT, IMPS, or cheque transfer.Cash deposits are not accepted.
Q:7 What if I do not have my client master report?
Answer: You should ask your broker for a copy of your client master report, as it is necessary for the transaction.
Q:8 How long does the process of buying unlisted shares take?
Answer: The process duration can vary, but once you confirm the booking and provide the necessary documents, it typically proceeds quickly.